Mangoceuticals (MGRX) Equity Ratio (2022 - 2026)

Mangoceuticals' Equity Ratio history runs 5 years deep, the most recent figure standing at 0.93 for Q1 2026.

• In Q1 2026, Equity Ratio changed 0.19% year-over-year to 0.93; the TTM figure through Mar 2026 stood at 0.93 (changed 0.19% YoY), while the FY2025 annual figure was 0.94, up 4.13% from the prior year.
• Equity Ratio came in at 0.93 for Q1 2026 at Mangoceuticals, down from 0.94 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.95 in Q3 2025 to a low of 3.18 in Q1 2024.
• A 5-year average of 0.59 and a median of 0.92 in 2025 frame the typical range for Equity Ratio.
• Across the five-year window, Equity Ratio tumbled 442.61% in 2024 and jumped 129.28% in 2025, its largest moves.
• Mangoceuticals' Equity Ratio stood at 0.61 in 2022, then advanced by 20.47% to 0.74 in 2023, then grew by 23.05% to 0.91 in 2024, then gained by 4.13% to 0.94 in 2025, then declined by 1.28% to 0.93 in 2026.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.93, 0.94, and 0.95 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison